Mechanistically, we show that CTSD suppresses the ubiquitination and degradation of BCL2, BCL-XL, and MCL1 mediated by the E3 ubiquitin ligase TRIM21, ultimately promoting the proliferation and survival of AML cells. This evidence concerns the gene BCL2 and acute myeloid leukemia.